138 filings
8-K
NTBL
Notable Labs Ltd
12 Apr 24
Notable Labs Reports 2023 Financial Results and Provides a Business Update
8:44am
8-K
NTBL
Notable Labs Ltd
9 Apr 24
Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024
5:20pm
8-K
NTBL
Notable Labs Ltd
8 Apr 24
Other Events
12:15pm
8-K
NTBL
Notable Labs Ltd
25 Mar 24
Submission of Matters to a Vote of Security Holders
9:00am
8-K
NTBL
Notable Labs Ltd
21 Mar 24
Changes in Registrant's Certifying Accountant
7:00pm
8-K
4rg b4dxwdp9n9
22 Feb 24
Other Events
8:15am
8-K
366f7qsk4sca7yrm1oo2
2 Feb 24
Changes in Registrant's Certifying Accountant
4:05pm
8-K
whntiti03
18 Dec 23
Other Events
8:15am
8-K/A
674g95 66r
29 Nov 23
Financial Statements and Exhibits
5:15pm
8-K/A
7z8 6pwoayo
29 Nov 23
Financial Statements and Exhibits
5:00pm
8-K
wywt1
14 Nov 23
Notable Labs Announces Filing of Form 10-Q for Third Quarter 2023
12:00am
8-K
vsy j3znp9w4u
20 Oct 23
Other Events
9:00am
8-K
y36 i9eyq
17 Oct 23
Regulation FD Disclosure
8:00am
8-K
fd88vi8qt8
16 Oct 23
Notable Labs Closes Merger Transaction With VBL Therapeutics
4:05pm
8-K
grbgaa 201tqkfd6ai
12 Oct 23
Submission of Matters to a Vote of Security Holders
4:26pm
8-K
m3mt lawi
10 Oct 23
Other Events
8:00am
8-K
igkab8s3ig erpu
2 Oct 23
Other Events
5:30pm
8-K
zeexv
18 Sep 23
Other Events
5:27pm
8-K
9bf3l0d
6 Sep 23
VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SEC
8:13am
8-K
9lnjb96y66kba
1 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm